LuluMedic Selected as Second-Party Operator for the "MyData Service Support Project"

Medical MyData platform company LuluMedic (CEO Kim Young-woong, Woo Sung-han) announced on the 5th that it has been selected for the 'MyData Service Support Project (Phase 2)' hosted by the Personal Information Protection Commission and the Korea Internet & Security Agency (KISA). Having previously been selected for the 'MyData Leading Service Support Project (Phase 1),' LuluMedic has now been selected for both the first and second rounds.

This selection was made as part of the expansion of the medical MyData system, which was fully implemented on March 13th, and LuluMedic is evaluated to have been comprehensively recognized for its service expandability, technological prowess, and data processing capabilities.

Through the second phase of its business, LuluMedic plans to provide a function that allows third parties, such as guardians or family members, to delegate access to medical data of the elderly, cognitively disabled, and minors with impaired cognitive function or immature self-determination capabilities.

Following the selection of its first operator, LuluMedic launched "d'stat," an integrated platform based on its capabilities in collecting, analyzing, and utilizing medical MyData. D'stat allows for integrated access to domestic medical records and medication history, and also features the ability to convert medical data into English and transmit it to overseas medical institutions.

Additionally, LuluMedic has been strengthening its global-level information security system through collaboration with Amazon Web Services (AWS) since June. LuluMedic is integrating AWS's AI technology into its platform and promoting integration with the global medical concierge service "Assist Card," aiming to enhance the convenience of healthcare for Koreans residing abroad.

A LuluMedic official stated, “This selection as a second operator is the result of the government once again recognizing our technological prowess and data reliability,” and “As the only company selected for both the first and second projects, we plan to focus on creating a platform ecosystem based on medical MyData and enhancing our services in the future.”


  • See more related articles